Each ophthalmic therapy reVision develops significantly addressing an unmet or poorly met need, even if it has limited exclusivity.
reVision reduces risk and cost by repurposing or rescuing products and getting patient, doctor, and payer commitment to product development, access, and supply duration, in return for lower prices that encourage access.
By finding a new way to commercialize, reVision seeks to change the drug price paradigm through free market competitive pressure, shifting the debate on drug costs away from imposing price controls, and undermining patents and innovation.
Sign up to receive updates, news, and more.
Please reach out to us with any concerns or special requests.